TY - JOUR
T1 - A polycythemia vera JAK2 mutation masquerading as a duodenal cancer mutation
AU - Lee, Justin
AU - Axilbund, Jennifer
AU - Brian Dalton, W.
AU - Laheru, Daniel
AU - Watkins, Stanley
AU - Chu, David
AU - Cravero, Karen
AU - Button, Berry
AU - Kyker-Snowman, Kelly
AU - Waters, Ian
AU - Gocke, Christopher D.
AU - Lauring, Josh
AU - Park, Ben Ho
N1 - Funding Information:
This work was supported in part by The Avon Foundation (B.H.P. and J.L.), NIH CA009071 (K.C. and B.H.P.), and the Sandy Garcia Charitable Foundation (D.C. and B.B.). Support was also received by NIH P30 CA006973, the Commonwealth Foundation, the Santa Fe Foundation, the Breast Cancer Research Foundation (B.H.P.), the ME Foundation, and the Augustine Fellowship (W.B.D.). None of the funding sources influenced the design, interpretation, or submission of this manuscript.
Publisher Copyright:
© 2016 JNCCN-Journal of the National Comprehensive Cancer Network.
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Next-generation sequencing (NGS) is increasingly being used in cancer care to identify both somatic tumor driver mutations that can be targeted for therapy, and heritable mutations in the germline associated with increased cancer risk. This report presents a case of a JAK2 V617F mutation falsely identified as a duodenal cancer mutation via NGS. The patient was found to have a history of polycythemia vera, a disorder with a high incidence of JAK2 somatic mutations. Buccal cell DNA showed heterozygosity for the mutation, suggesting that it was potentially germline. However, subsequent resequencing of tumor, adjacent normal tissue, and fingernail DNA confirmed the mutation was somatic, and its presence in tumor and buccal cells resulted from contaminating blood cells. This report highlights important nuances of NGS that can lead to misinterpretation of results with potential clinical implications.
AB - Next-generation sequencing (NGS) is increasingly being used in cancer care to identify both somatic tumor driver mutations that can be targeted for therapy, and heritable mutations in the germline associated with increased cancer risk. This report presents a case of a JAK2 V617F mutation falsely identified as a duodenal cancer mutation via NGS. The patient was found to have a history of polycythemia vera, a disorder with a high incidence of JAK2 somatic mutations. Buccal cell DNA showed heterozygosity for the mutation, suggesting that it was potentially germline. However, subsequent resequencing of tumor, adjacent normal tissue, and fingernail DNA confirmed the mutation was somatic, and its presence in tumor and buccal cells resulted from contaminating blood cells. This report highlights important nuances of NGS that can lead to misinterpretation of results with potential clinical implications.
UR - http://www.scopus.com/inward/record.url?scp=85006056573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85006056573&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2016.0161
DO - 10.6004/jnccn.2016.0161
M3 - Article
C2 - 27956534
AN - SCOPUS:85006056573
VL - 14
SP - 1495
EP - 1498
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
SN - 1540-1405
IS - 12
ER -